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Abstract
Background: Differentiating sepsis from the systemic inflammatory response syndrome (SIRS) in critical care
patients is challenging, especially before serious organ damage is evident, and with variable clinical presentations
of patients and variable training and experience of attending physicians. Our objective was to describe and
quantify physician agreement in diagnosing SIRS or sepsis in critical care patients as a function of available
clinical information, infection site, and hospital setting.
Methods: We conducted a post hoc analysis of previously collected data from a prospective, observational trial
(N = 249 subjects) in intensive care units at seven US hospitals, in which physicians at different stages of patient
care were asked to make diagnostic calls of either SIRS, sepsis, or indeterminate, based on varying amounts of
available clinical information (clinicaltrials.gov identifier: NCT02127502). The overall percent agreement and the
free-marginal, inter-observer agreement statistic kappa (κfree) were used to quantify agreement between evaluators
(attending physicians, site investigators, external expert panelists). Logistic regression and machine learning techniques
were used to search for significant variables that could explain heterogeneity within the indeterminate and SIRS
patient subgroups.
Results: Free-marginal kappa decreased between the initial impression of the attending physician and (1) the initial
impression of the site investigator (κfree 0.68), (2) the consensus discharge diagnosis of the site investigators (κfree 0.62),
and (3) the consensus diagnosis of the external expert panel (κfree 0.58). In contrast, agreement was greatest between
the consensus discharge impression of site investigators and the consensus diagnosis of the external expert panel (κfree
0.79). When stratified by infection site, κfree for agreement between initial and later diagnoses had a mean value + 0.24
(range − 0.29 to + 0.39) for respiratory infections, compared to + 0.70 (range + 0.42 to + 0.88) for abdominal + urinary +
other infections. Bioinformatics analysis failed to clearly resolve the indeterminate diagnoses and also failed to explain
why 60% of SIRS patients were treated with antibiotics.
(Continued on next page)
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Conclusions: Considerable uncertainty surrounds the differential clinical diagnosis of sepsis vs. SIRS, especially before
organ damage has become highly evident, and for patients presenting with respiratory clinical signs. Our findings
underscore the need to provide physicians with accurate, timely diagnostic information in evaluating possible sepsis.
Keywords: Sepsis, Diagnosis, Inter-observer agreement, Intensive care

Impact statement/at a glance commentary
The differential diagnosis of sepsis vs. systemic inflammatory response syndrome (SIRS) in intensive care unit
(ICU) patients remains challenging. We studied physician agreement in patients admitted to ICUs for the
task of performing this differential diagnosis. Our findings suggest that uncertainty in this diagnosis has multifactorial causes: physician training and experience;
availability of relevant clinical information (i.e., clinical
microbiology tests, antigen- or molecular-based pathogen detection tests, and radiology); and identification of
the source of infection (if known or present). We observed the least agreement between or among physicians
for diagnosing sepsis in patients with respiratory clinical
signs. Our findings underscore the need for objective
diagnostics to be applied at the earliest possible time for
critically ill patients suspected of infection.
Background
Diagnosis of sepsis remains a challenge for myriad reasons [1]. A physician may first begin to suspect sepsis in
the early stages of the disease, before organ damage is
evident, when clinical signs can be either absent, varied,
or clinically indistinguishable from systemic inflammation due to non-infectious causes. Further, for patients
suspected of sepsis, clinical microbiology tests may be
negative but when positive often require two or more
days to produce actionable results. These microbiologic
data suffer from significant numbers of false-positives
and false-negatives when attempting to identify the actual microbial cause of sepsis [2, 3]. Early diagnosis of
sepsis is important because intervention could potentially have the greatest patient benefit early in the disease
course [4, 5]. However, inaccuracies in early sepsis diagnosis could have significant potential consequences for
patients including excessive use of empiric, broadspectrum antibiotics, inappropriate management, longterm morbidity, or death [6–8].
Sepsis definitions have evolved significantly over the
last 30 years [9–12]. The early Sepsis-1 definition [9]
described a septic syndrome which included clinical
evidence of an infection along with fever or
hypothermia, tachypnea, tachycardia, and evidence of
impaired organ perfusion or function as manifested by
either altered mentation, hypoxemia, elevated plasma

lactate, or oliguria. Only 45% of patients with septic
syndrome in this study were blood culture positive.
Following from this, Bone et al. [10] introduced a definition for systemic inflammatory response syndrome
(SIRS) and defined sepsis as an infection or suspected
infection leading to SIRS. In 2001, a Sepsis-2 definition included at least two SIRS criteria and a suspected or confirmed infection [11]. In the Sepsis-3
definition, SIRS criteria are deemed to not be ideal
clinical markers for sepsis, especially since it has been
shown in a large study that 12% of patients with confirmed sepsis do not show clinical signs of SIRS [13]
and since SIRS criteria are present in many hospitalized patients without infection [14]. Instead, the
Sepsis-3 definition relies on an increase of the
sequential organ failure assessment (SOFA) score of 2
points or more to determine organ dysfunction
associated with a higher risk of in-hospital mortality.
Thus, even after 30 years of effort, sepsis definitions
continue to evolve. Singer et al. [12] state “there are,
as yet, no simple and unambiguous clinical criteria, or
biological, imaging, or laboratory features that uniquely
identify a septic patient.” The Sepsis-3 definition, while
seemingly an improvement in operational terms,
nonetheless has been criticized because it shifts the emphasis to organ dysfunction, thus de-emphasizing detection and intervention at earlier stages when the
disease is most easily treated [15–17].
In the absence of an unambiguous definition of sepsis
and highly accurate diagnostic tools, physicians rely on
their own clinical skill set and experience to diagnose
sepsis. However, it has been shown that clinical diagnosis of sepsis upon admission to ICU corresponds poorly
with post hoc presence of infection [18] and that agreement among physicians within specific sepsis diagnostic
subgroups varies considerably [19].
Our study objective was to further identify and delineate factors contributing to the difficulty of the early
diagnosis of sepsis, by quantifying the agreement between physicians for sepsis diagnosis in a cohort of adult
patients prospectively enrolled in a multi-site clinical
trial [20]. There are three ways in which our study extends previous work in this area: (1) it quantifies the
physician agreement in sepsis diagnosis as a function of
timing and availability of clinical information, physician
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training/experience level, hospital location, and infection
site; (2) it offers a multivariate analysis of the observed
heterogeneity within the patient group having indeterminate diagnoses; and (3) it employs machine learning
methods to search for significant combinations of clinical variables that could explain a split of SIRS patients
into those receiving vs. not receiving systemic antibiotics. An early version of this work has been presented
in the form of an abstract [21].

Methods
Study definitions

Sepsis-3, the third international consensus definition of
sepsis [12], represents a significant change from previous
definitions of sepsis, giving emphasis to organ dysfunction
and dysregulated immune response to infection. However,
the present study employed the earlier Sepsis-2 definitions
of systemic inflammatory response syndrome (SIRS) and
sepsis [11] for several reasons: (1) the study was designed
and initiated before the Sepsis-3 definition was published;
(2) the Sepsis-3 definition is not particularly helpful to
physicians for determining whether or not a patient suspected of sepsis has an infection, particularly in the early
stages before organ dysfunction is evident [22]; and (3) in
the USA, the Centers for Medicare and Medicaid Services
(CMS) still use the Sepsis-2 definition for regulatory and
reimbursement purposes; thus this definition is still used
in practice [23].
In the present study, SIRS was defined as the presence
of two or more clinical signs of systemic inflammation
[10, 11] combined with (1) no apparent site of infection
identified at admission or during hospitalization; (2) an
alternative, non-infectious explanation for the signs of
systemic inflammation; or (3) no microbial pathogen
identified by culture, serologic, or antigen-based testing.
Sepsis was defined by the presence of two or more signs
of systemic inflammation, combined with a site of infection identified at admission or during early
hospitalization, either with pathogen identification (“definite” infection) or without (“probable” infection). A
diagnosis of “indeterminate” was defined as the combination of (1) two or more signs of systemic inflammation;
(2) a possible non-infectious cause; and (3) a potential
site of infection or an organism identified by culture,
serologic, or antigen-based testing from a non-sterile
site.
Study cohort

We conducted a post hoc analysis of patient data from a
prospective observational study [20], entitled Validation
of septic gene ExpressioN Using SeptiCyte (VENUS)
which was conducted at the Intermountain Medical
Center (IMC), Murray, UT (N = 125) and LDS Hospital
(LDSH), Salt Lake City, UT (N = 4) between April 2013
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and April 2014. This study had a supplement, conducted
between March 2016 and August 2016, that enrolled
120 additional patients from five academic institutions
in major US metropolitan areas: Johns Hopkins Hospital
(JHH), Baltimore, MD (N = 39); Rush University Medical
Center (RUMC), Chicago, IL (N = 37); Loyola University
Medical Center (LUMC), Maywood, IL (N = 11); Northwell Healthcare (NH), Long Island, NY (N = 26); and
Grady Memorial Hospital (GMH), Atlanta, GA (N = 7).
The VENUS and VENUS supplement patients (N = 249)
are herein together referred to as the “USA Cohort.”
The VENUS and VENUS supplement cohorts were recruited under the same study protocol (clinicaltrials.gov
identifier: NCT02127502) and employed the same inclusion and exclusion criteria. The VENUS and VENUS
supplement cohorts were recruited as the US component of a parent study, involving a total of 447 patients
that was powered to evaluate the diagnostic performance
of a new molecular test, SeptiCyte LAB, for distinguishing sepsis from SIRS in adult critical care patients [20].
Patient inclusion and exclusion criteria
Inclusion criteria

Adults (18–89 years) were considered for enrollment in
the study if they displayed an accumulation (usually in
the ED) of two or more clinical signs of systemic inflammation (temperature > 38 °C or < 36 °C, heart rate > 90
beat/min, tachypnea > 20/min or PaCO2 < 32 mm Hg,
white blood cell count > 12,000/mm3 or < 4000/mm3, or
> 10% immature neutrophils) in the 24-hour period prior
to being considered for enrollment. Enrollment occurred
within 24 h of admission to ICU. Informed consent was
obtained for each subject, either directly or through a legally authorized representative.
Exclusion criteria

Subjects were excluded if consent was not obtained, if
bacterial infection was suspected but no microbiology
cultures were collected, if admitted to ICU for ≥ 24 h before consent or study enrollment, or if undergoing elective cardiac surgery with an expected ICU stay of < 24 h.
Clinical diagnostic methods

Clinical diagnoses at each study site were performed
using four methods that differed with respect to the extent of training and experience of the evaluators and also
to the timing and the amount of clinical information
available (Table 1).
Initial assessment (attending physician)

An initial clinical assessment was performed by the attending physician using clinical data available within 24
h of ICU admission as part of routine care, independent
of the present study. The attending physician was
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Table 1 Clinical diagnostic methods
Classification method
1. Initial assessment: attending 2. Initial assessment: site
physician
investigator

3. Discharge assessment: site
investigators

4. External RPD

By:

Attending physician
(N = 1)

Site investigator
(N = 1)

Site investigators
(N = 2)

External expert panel
(N = 3)

When:

Within 24 h of admission to
ICU

Within 48 h of admission to ICU At discharge from ICU
(nearly always within 24 h)

Using:

Clinical signs at admission and Clinical signs at admission and
basic laboratory and radiology basic laboratory and radiology
results
results

• Retrospective data (first 24 h
in ICU)
• Microbiology
• Non-culture based pathogen detection results
• Radiology

• Retrospective data
(first 24 h in ICU)
• Microbiology
• Non-culture-based pathogen detecti
on results
• Radiology
• Retrospective discharge assessment

Output

SIRS/indeterminate/sepsis

SIRS/indeterminate/sepsis

SIRS/indeterminate/sepsis

SIRS/indeterminate/sepsis

None

If site investigators do not
agree, then 3rd independent
physician’s vote taken

Full agreement = SIRS or sepsis
2/3 agreement = SIRS or sepsis
No agreement = Indeterminate

Adjudication None

required to make a diagnostic call of infection status
(none, possible, probable, or definite) [18, 19, 24]. When
one of the site investigators was the admitting physician,
this investigator’s initial clinical impression served as the
attending physician impression. This assessment was
made before culture results became available and represents routine clinical practice.
Note: in the subsequent analysis of data from the attending physicians, an infection status of “none” was
assigned to the SIRS category, an infection status of
“possible” was assigned to the indeterminate category,
and an infection status of “probable” or “definite” was
assigned to the sepsis category. This converted the attending physician assessments into a format consistent
with the assessments performed by the site investigators
and external panelists (below).

Initial assessment (site investigator)

An initial assessment was also performed by one of the
two site investigators who was not the treating physician.
A site investigator never provided both attending and investigator initial clinical impressions. Site investigators
included pulmonary intensivists and infectious diseases
specialists. The site investigator’s assessment was made
using clinical data available within 24 h of admission and
did not include an independent physical examination or
culture results. Site investigators were required to make
one of the following diagnostic calls: no infection (SIRS),
possible infection (indeterminate), probable infection
(sepsis), or definite infection (sepsis). This method aimed
to most closely resemble a case referred to an experienced infectious disease or critical care specialist, who
was then required to make an initial clinical impression
based on currently available clinical information.

Following discharge
from ICU

Discharge assessment (site investigators’ consensus)

A discharge evaluation was performed independently by
the two site investigators who examined each subject’s
medical record from admission to hospital discharge.
This assessment used only the portion of the complete
medical record that was relevant to the systemic inflammation observed during the initial 24–48-h period in
ICU. Clinical evaluation and workup was determined by
the treating physician. Tests that the site investigators
reviewed to establish a discharge diagnosis included clinical notes, radiographic data, operative notes, pathology
reports, culture results, and/or results of antigen- or
molecular-based pathogen detection tests. Cultures were
collected based on the suspected site of infection (e.g.,
blood, urine, wound, respiratory tract, etc.). Positive test
results were interpreted in conjunction with the clinical
scenario to establish a diagnosis. Site investigators were
required to make one of the following diagnostic calls:
no infection (SIRS), possible infection (indeterminate),
probable infection (sepsis), or definite infection (sepsis).
Disagreement in diagnostic calls between the two site investigators triggered an independent review by an
equally qualified adjudicator. Using this method, a disagreement between all three evaluators, or a diagnostic
call of “possible” by all three evaluators, was classified as
indeterminate. This method aimed to establish a reference call made by on-site investigators (“local
reference”).
Retrospective physician diagnosis (RPD)

An independent panel of three external expert physicians performed a final discharge assessment for each
enrolled patient, which served as the gold standard (“external reference”) for the diagnosis of sepsis or SIRS.
Each panel member was a senior physician with
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expertise across intensive care medicine, emergency
medicine, and/or infectious diseases but was not involved in the patient’s care and did not have access to
the full patient medical records. All patient case review
forms (CRFs) containing the study subjects’ collection
site and clinical information in a standardized format
were forwarded to each panel member. The panel members were also given access to the consensus discharge
evaluations made by the site investigators. The diagnostic call options were no infection (SIRS), possible infection (indeterminate), probable infection (sepsis), and
definite infection (sepsis). This method aimed to match
previously published studies [18, 19, 24] and was viewed
as the gold standard for diagnosing sepsis because it incorporated all the earlier clinical data and judgments,
drew upon the RPD panelists’ broad expertise, and
helped to ensure a consistent interpretation of clinical
data across study sites.

Diagnostic comparisons

To quantify the agreement between pairs of clinical evaluations, we computed the overall percent agreement and
also two versions (fixed-marginal and free-marginal) of
the inter-observer agreement statistic kappa (denoted by
the symbols κfixed and κfree, respectively). Details are provided in Additional file 1. The following letters (A–K)
are used throughout the manuscript and its supplements, to denote the following comparisons:
A. Initial assessment (attending physician) versus initial assessment (site investigator), in an attempt to delineate the influence of different levels of physician training
and experience
B. Initial assessment (attending physician) versus consensus discharge assessment (site investigators), in an attempt to compare the accuracy of an attending
physician’s initial impression with the locally determined
reference diagnosis (local reference)
C. Initial assessment (attending physician) versus consensus RPD (external panelists) to compare accuracy of
an attending physician’s initial impression with the expert reference diagnosis (external reference)
D. Initial assessment (site investigator) versus consensus discharge assessment (site investigators), in an attempt to delineate the influence of diagnostic test results
on clinical impression
E. Initial assessment (site investigator) versus consensus RPD (external panelists), in an attempt to delineate
the influence of physician training and experience level,
and of diagnostic test results
F. Consensus discharge assessment by site investigators versus consensus RPD (external panelists), in an attempt to understand the variability that may occur in a
panel of experienced physicians
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G, H, I. Comparisons between individual RPD evaluations in an attempt to delineate or quantify the baseline
level of disagreement (“diagnostic noise”) inherent in the
de facto gold standard
J. Comparisons between the discharge assessments of
site investigators
K. Unanimous Agreement, representing the highest
degree of diagnostic certainty. We defined “unanimous”
to mean that the site investigators’ consensus discharge
assessment and the individual evaluations by the three
external RPD panelists were in complete agreement regarding the diagnosis of SIRS or sepsis. If the agreement
was less than unanimous, then an indeterminate call was
made under this evaluation method.
Note that comparison (F) was expected to display a
relatively high level of agreement because the external
panel was given access to the site investigators’ consensus discharge evaluations; thus comparison (F) provides
a realistic upper bound on expected agreement values.
Agreement between various clinical evaluations was
quantified by the overall percent agreement and also by
two variants of the inter-observer kappa statistic. The
commonly used Cohen’s kappa or fixed-marginal variant
κfixed [25, 26] was unsuitable for those comparisons involving small numbers of samples; instead, we used Randolph’s free-marginal multirater kappa κfree [27], which
is well-defined and robust in this context. Further details
on these statistics are provided in Additional file 1. A
line data file is provided in Additional file 2.
Statistical and bioinformatics analyses

Differences between proportions were evaluated for significance using a two-proportion Z-test (http://
www.socscistatistics.com/tests/ztest/Default2.aspx) when
sample sizes were large (n*p > 5). For small sample sizes
(n*p < 5), an N-1 chi-square test was used instead
(https://measuringu.com/ab-cal/). Two-tailed tests were
employed. The Kolmogorov-Smirnov test was used to
check for significance of differences between cumulative
distributions, using an applet available at www.physics.csbsju.edu/stats/KS-test.html. The significance (p
value) of the D statistic was checked with the online calculator at http://home.ubalt.edu/ntsbarsh/Business-stat/
otherapplets/pvalues.htm#rkstwo.
We performed logistic regression followed by receiver operating characteristic (ROC) curve analysis, in an attempt to
identify factors that could stratify the indeterminate subjects
or identify underlying similarities to SIRS or sepsis archetypes. To perform these calculations, an online logistic regression calculator (http://statpages.info/logistic.html) and an
online ROC curve calculator (http://www.rad.jhmi.edu/jeng/
javarad/roc/JROCFITi.html) were used.
We also analyzed the SIRS patient subgroup (106/249;
42.6% of total, as defined by unanimous agreement) by
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machine learning methods, in an attempt to identify factors that could explain the treat/no treat decision. We
tried several approaches. (1) From the line data file, we
selected a pool of twelve multi-valued parameters
(N.SIRS, ICU.LoS, Hospital.LOS, Age, HeartRate.Max,
HeartRate.Min, APACHE.Score, Mean.Art.Pressure.Min,
WBC.Max, WBC.Min, Glucose.Max, Glucose.Min) and
eight binary-valued (+/−) parameters (culture.blood, culture.drain, culture.pus, culture.respiratory, culture.skin,
culture.sputum, culture.urine, culture.other.contaminants). Then, using either logistic regression or Random
Forests [28, 29] and a recursive feature elimination
process [30, 31], we searched for classifiers (combinations of the above parameters) that could discriminate
between treated and untreated SIRS patients. (2) We
performed a linguistic analysis of single words and word
pairs in the “physician comment” field of the case report,
using a Random Forests approach, in a further attempt
to discriminate between treated and untreated SIRS patients. (3) Finally, we pooled the most informative clinical and demographic parameters, words, and word-pairs
from above, and repeated the recursive feature elimination using either logistic regression or Random Forests.

Results
Description of study cohorts

Our study enrolled 249 patients with demographic and
clinical characteristics presented in Table 2. With the
unanimous diagnostic method, which is arguably the
most accurate because it requires perfect agreement between the consensus discharge diagnosis and all three
RPD panelists, 106/249 (42.6%) of subjects were diagnosed as SIRS, 69/249 (27.8%) were diagnosed as sepsis,
and 74/249 (29.7%) of subjects were assigned an indeterminate status. Pneumonia was the most commonly identified infection site (42/249; 16.9%). Patients with an
indeterminate diagnosis, or who were unanimously diagnosed with sepsis, were older and had longer stays in
ICU and hospital and also had a higher median Acute
Physiology and Chronic Health Evaluation (APACHE)
score compared to patients diagnosed as SIRS.
Comparison of initial assessment to later assessments

We compared the initial assessment by the attending
physician to the initial and discharge assessments by the
site investigator(s) and also to the external discharge RPD.
Figure 1a summarizes the percent overall agreement and
inter-observer kappa values for these comparisons. The
fixed-marginal kappa (κfixed) between initial clinical impressions by the attending physician and site investigator
was moderate at 0.64 (95% CI 0.56–0.72). The value of
κfixed between the initial assessment by the attending physician and the retrospective discharge assessment by the
site investigators was marginally lower at 0.58 (95% CI
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0.49–0.67). The value of κfixed between initial assessment
by the attending physician and the external RPD was
lower still at 0.53 (95% CI 0.44–0.62). Thus, we found an
apparent trend of decreasing fixed-marginal kappa (κfixed
0.64 ➔ 0.58 ➔ 0.53) between the initial impression made
by treating physicians and final diagnoses as determined
by the local and expert panels. The free-marginal kappa
values (κfree) followed the same trend but were slightly
higher than their fixed-marginal counterparts.
We also compared the initial assessment by the attending physician and the initial and discharge assessments by
the site investigator(s) to the external RPD gold standard
(Fig. 1b). We found that the reference diagnosis as determined by the RPD panel agreed better with initial impressions made by the site investigators (κfixed 0.64) than with
the initial impressions of the attending physician (κfixed
0.53). We also observed that the consensus discharge impression of site investigators had a moderate and greatest
agreement with the consensus of the external RPD panelists (κfixed 0.76). The free-marginal kappa values (κfree)
followed the same trend but were slightly higher than
their fixed-marginal counterparts (Fig. 1b).
A difference in agreement between the initial and later
assessments is reflective of the influences that cumulative
test results and response to empiric therapy may have on
clinical impressions. We also categorized the degree of
risk and theoretical impact that initial misdiagnosis would
have on treatment decisions and patient outcome (Table 3
and Additional file 3). An increased apparent risk for poor
outcome was considered to occur if a patient was initially
assessed as SIRS or indeterminate but was then reclassified later as indeterminate or sepsis. By this measure, 21
patients (8.4%) had an increase in apparent risk with four
(1.6%) initially thought to have SIRS but ultimately determined to be septic by the local panel diagnosis. This difference was greater when compared to the external RPD
(Table 3 and Additional file 3).
Stratification by infection site

We examined the agreement between initial assessment
and later diagnosis based on infection site. We stratified
the cohort into the following categories of infection site:
non-pneumonia respiratory, pneumonia, abdominal,
urinary tract, other site, or not identified (Fig. 2). The
category “not identified” was considered to be equivalent
to a diagnosis of SIRS. This analysis employed the overall percent agreement and the free-marginal kappa (κfree)
as appropriate for small sample sizes.
We observed that the lowest levels of diagnostic agreement between initial and later diagnoses were found for
both categories of respiratory infection (pneumonia and
non-pneumonia), with the free-marginal kappa (κfree)
having a mean value of + 0.24 (range − 0.29 to + 0.39)
for respiratory infections, compared to + 0.70 (range
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Table 2 Demographic and clinical characteristics of the study cohort (N=249). Comparator = unanimous method, meaning that the
site investigators’ consensus discharge assessment and the individual evaluations by the three external RPD panelists were in
complete agreement, regarding the diagnosis of SIRS or sepsis. If the agreement was less than unanimous, then an indeterminate
call was made
Parameter category

Parameter

SIRS (n = 106)

Sepsis (n = 69)

Indeterminate
(n = 74)

p value1

Demographics

Age: median (IQR)

54 (40–65)

60 (47–67)

64 (53–75)

0.002

Sex: female

51 (48%)

30 (44%)

36 (49%)

0.79

White

68 (64%)

41 (59%)

53 (72%)

0.30

Black

30 (28%)

16 (23%)

16 (22%)

0.55

Asian/East Indian

2 (2%)

6 (9%)

2 (3%)

0.06

Hispanic

4 (4%)

5 (7%)

3 (4%)

0.54

Other or unrecorded

2 (2%)

1 (1%)

0

0.51

1. No blood culture done or blood culture negative

100 (94%)

11 (16%)

66 (89%)

< 0.001

2. Blood culture positive

3 (3%)

29 (42%)

4 (5%)

< 0.001

3. Gram positive

3 (3%)

13 (19%)

3 (4%)

< 0.001

4. Gram negative

0

11 (16%)

1 (1%)

< 0.001

5. Mixed Gram pos/neg

0

5 (7%)

0

0.001

6. Fungus

0

0

0

NA

Respiratory tract (non-lung)

0

3 (4%)

4 (5%)

0.06

Lung (pneumonia)

3 (3%)

15 (22%)

24 (32%)

< 0.001

Abdominal

0

10 (14%)

2 (3%)

< 0.001

Urinary tract

0

8 (12%)

3 (4%)

0.001

Other site

0

21 (30%)

4 (5%)

< 0.001

Not identified

103 (97%)

12 (17%)

37 (50%)

< 0.001

Blood culture result

Infection site

Clinical parameters, outcome

Days in hospital: median (IQR)

3 (2–5)

8 (5–14)

Days in ICU: median (IQR)

2 (1–2)

3 (2–5)

3

6 (4–9)

< 0.001

2 (1–4)

0.002

Antibiotics given in ICU

60 (57%)

68 (99%)

68 (92%)

< 0.001

APACHE score: median (IQR)2

54 (29–84)

76 (46–95)3

82 (48–103)4

< 0.001

SOFA score: median (IQR)

4 (2–7)6

5 (4–10)5

6 (4–8)7

0.02

9 (12%)

0.18

Mortality

6 (6%)

3

9 (13%)

Abbreviations: ANOVA analysis of variance, APACHE Acute Physiology and Chronic Health Evaluation, ICU intensive care unit, IQR inter-quartile range, NC not
calculated, neg negative, pos positive, RPD retrospective physician diagnosis, SOFA sequential organ failure assessment
1
For distributions (like age), the p value is derived from ANOVA. For categorical variables such as sex, the p value is derived from a three-sample test for equality
of proportions without continuity correction. p values derived from small samples should not be considered definitive.
2
APACHE score, as calculated at different clinical sites (site, version, available to RPD panelists): IMH III yes; LDSH III yes; JHH III no; NH IV no; RUMC II yes; LUMC III
no; GMH III no.
3
68/69 sepsis patients with data recorded
4
73/74 indeterminate patients with data recorded
5
55/69 sepsis patients with data recorded
6
70/106 SIRS patients with data recorded
7
60/74 indeterminate patients with data recorded

0.42 to 0.88) for all other infections. For cases where no
infection site could be identified (i.e., presumptive SIRS),
the free-marginal kappa (κfree) had a mean value of 0.74
(range 0.67 to 0.79).
The low agreement between physicians for patients with
respiratory infections could not be attributed solely to differences between initial and later diagnoses. This was
shown by the comparisons labeled “control” in Fig. 2, in
which agreement for respiratory infections was measured
for the site investigators’ consensus discharge assessment

vs. RPD (F), and between pairs of RPD panelists (G, H, I).
These control comparisons for respiratory infection
sources show a much lower degree of agreement (κfree =
0.50) relative to comparisons involving other infection
sources (κfree = 0.70) or SIRS (κfree = 0.74). Thus, sepsis
cases of respiratory origin appear inherently difficult to
diagnose, regardless of clinical data gathered during a patient’s ICU stay and regardless of the point at which the
diagnosis is being attempted (ICU admission, ICU discharge, or external RPD). Additional details of the analysis
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Fig. 1 Agreement between diagnostic methods. a Comparisons 1, 2, and 3: initial assessment by attending physician vs. initial assessment by site investigator.
Comparisons 4, 5, and 6: initial assessment by attending physician vs. discharge assessment by site investigators. Comparisons 7, 8, and 9: initial assessment by
attending physician vs. external RPD. Agreement with the initial assessment by attending physician decreases (fixed-marginal kappa κfixed 0.64 ➔ 0.58 ➔ 0.53)
as more diagnostic information becomes available, as physician training and experience increases, and as time pressure to make a diagnostic call decreases. b
Comparisons 7, 8, and 9: initial assessment by attending physician vs. external RPD. Comparisons 10, 11, and 12: initial assessment by site investigator vs.
external RPD. Comparisons 13, 14, and 15: consensus discharge assessment by site investigators vs. external RPD. The numerals and symbols in this figure have
the following meanings: 1, 4, 7, 10, and 13: VENUS cohort (V; 129 subjects); 2, 5, 8, 11, and 14: VENUS supplemental cohort (Vs; 120 subjects); 3, 6, 9, 12, 15:
VENUS + VENUS supplemental cohorts (V + Vs; 249 subjects); blue diamonds = overall agreement; green triangles = free-marginal kappa κfree; red squares =
fixed-marginal kappa κfixed

of the patients with pneumonia or other respiratory infections are presented in Additional file 4.
We attempted to identify clinical variables that could
help to explain the differences in inter-observer agreement between patients with respiratory infections versus
other types of infection. We stratified patients into the
following two subgroups with respect to infection site:

respiratory (pneumonia + non-pneumonia) versus
non-respiratory (abdominal + urinary + other). We then
used statistical tests (t test or 2-proportions z test) to ascertain if clinical variables could be identified that displayed significantly different values between these two
subgroups (Table 4). The respiratory infection subgroup
had a significantly higher percentage of patients
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Table 3 Analysis of Reclassification Events
Reclassification

Number (%) reclassified: attending
Number (%) reclassified: attending Change in
physician ➔ discharge evaluation
physician ➔ RPD (Additional file 3: apparent in
by site investigators (Additional file 3: Figure S3–2)
risk profile
Figure S3–1)

Potential consequence of
erroneous initial classification

SIRS to sepsis

4 (1.6%)

6 (2.4%)

Low to high

Delayed antibiotic treatment,
prolonged hospital stay, and
increased morbidity and mortality

Indeterminate
to sepsis

12 (4.8%)

22 (8.8%)

Medium to
high

Possible delayed antibiotic
treatment

SIRS to
indeterminate

5 (2.0%)

5 (2.0%)

Low to
medium

Possible delayed antibiotic
treatment

Sepsis to SIRS

9 (3.6%)

9 (3.6%)

High to low

Excess antibiotic use

Indeterminate to
SIRS

18 (7.2%)

16 (6.4%)

Medium to low

Possible excess antibiotic use

Sepsis to
indeterminate

15 (6.0%)

12 (4.8%)

High to
medium

Possible excess antibiotic use

Total

63 (25.3%)

70 (28.1%)

diagnosed as indeterminate, with lower procalcitonin
(PCT) values, lower maximum body temperature (T
Max), and higher mean arterial pressure (MAP) compared to patients in the non-respiratory infection
subgroup.
Stratification by hospital

We stratified our cohort with respect to different hospitals and then evaluated the agreement among different
diagnostic methods. This analysis employed the
free-marginal kappa (κfree) as appropriate for small sample sizes. We observed significant differences among
hospitals with respect to the level of agreement among
methods (Additional file 5). The cause(s) of the differences among hospitals were not obvious. Patients from
some hospitals could have been more difficult to diagnose, due to differences in presentation or severity of
clinical signs. Alternatively, the explanation might reside
in differences in training or institutional practices.
Analysis of indeterminate diagnoses

The classification methods of Table 1 allowed for patients to have a final designation of “indeterminate”
when physicians were unable to make a clear classification of either sepsis or SIRS, or when retrospective panel
designations were contradictory. For patients classified
as indeterminate, we found that certain clinical variables
were able to discriminate indeterminates from either
sepsis or SIRS but not simultaneously from both groups.
However, there were no composite clinical variables that
clearly achieved a three-way discrimination between
SIRS, sepsis, and indeterminate groups. The two ROC
curves of Fig. 3 illustrate the results of a logistic regression analysis. In panel a, a logistic combination of the
variables SeptiScore, WBC.Max, WBC.Min, and MAP.Max differentiated 64 septic patients from 23

indeterminates with an AUC of 0.79 (95% CI 0.68–0.90).
Similarly, a logistic combination of log2 PCT and SeptiScore differentiated 73 SIRS patients from 15 indeterminates with an AUC of 0.81 (95% CI 0.69–0.92). Thus, it
appears that a major difficulty in resolving indeterminates into either the SIRS or sepsis category reflects an
inherent clinical uncertainty which is not resolved by patient signs and symptoms and diagnostic tests. Further
details on this analysis are provided in Additional file 6.
Antibiotic use

Antibiotics were administered to 60/106 (56.6%) of patients unanimously diagnosed as SIRS, 78/78 (100.0%)
patients unanimously diagnosed as sepsis, and 59/65
(90.8%) of indeterminate patients (Fig. 4). We searched
for individual factors underlying the physicians’ decisions to give antibiotics to only a subset of SIRS patients.
This analysis is described in Table 5 and Additional file 7.
At least five clinical and demographic parameters (low
MAP, tachycardia, fever, number of SIRS criteria
(N.SIRS), and increased hospital length of stay (H.LoS))
showed some ability individually (p < 0.05 in t test) to
distinguish between SIRS patients who were either
treated or not treated with antibiotics. The four variables
MAP, tachycardia, fever, and N.SIRS, either with or without the increased H.LoS, were combined in logistic regression, and the resultant predictor was able to achieve
a partial discrimination (AUC 0.71–0.72), as shown in
Fig. 5a, b.
These results appear to suggest that physicians may
rely on clinical and demographic parameters, perhaps
embodied in intuitive judgments, as the basis of antibiotic treatment decisions in these SIRS patients. To further explore this possibility, we performed a more
sophisticated machine-learning analysis, in which we
used recursive feature elimination, logistic regression,
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Fig. 2 Plot of percent overall agreement and free-marginal kappa (κfree) for diagnostic method comparisons stratified by site of infection. For each infection
site, the following comparisons were performed: (B) initial assessment by attending physician vs. consensus discharge assessment by site investigators; (C) initial
assessment by attending physician vs. external RPD; (D) initial assessment by site investigator vs. consensus discharge assessment; and (E) initial assessment by
site investigator vs. external RPD. As a control, the following comparisons were performed for respiratory infection samples including pneumonia (N = 49): (F)
consensus discharge assessment vs. external RPD; (G) RPD panelists 1 vs. 2; (H) RPD panelists 1 vs. 3; (I) RPD panelists 2 vs. 3. Note: the number of subjects in
the various categories add up to 250 (not 249) because the infection site for one sepsis case was diagnosed as both abdominal and pneumonia. “SIRS”
indicates that no site of infection was identified. Horizontal blue bars indicate average values for the free-marginal kappa statistic, over the indicated comparisons

Random Forests, and textual analysis of the “physicians
comments” field in the case reports, to identify combinations of parameters that could discriminate between
treated and untreated patients in the SIRS group. Results
are described in Additional file 7. The conclusion we
reached is that no combination of clinical, demographic,
or textual variables was able to distinguish between
treated vs. untreated patients in the SIRS group with an
AUC greater than approximately 0.7.

Discussion
Despite the evolution and improvement of sepsis definitions over the past three decades [9–12], clinicians still
have difficulty identifying patients who are becoming septic, especially early in the process before organ dysfunction has become severe. Previous attempts have been
made to describe the difficulty in diagnosing sepsis in
quantitative terms, through measuring agreement between
physician diagnoses and sepsis definitions [32–34],

Table 4 Parameters that vary significantly between different infection site subgroups
p value1

Parameter

Mean ± SD (non-respiratory)

Mean ± SD (respiratory)

Number in group

48

49

Overall agreement

0.85 ± 0.05

0.62 ± 0.08

6.0E-09

Free-marginal κ

0.77 ± 0.07

0.43 ± 0.12

6.8E-09

No. of indeterminates
(identified by discharge consensus assessment)

6/48 = 12.5%

15/49 = 30.6%

0.030

Lowest MAP

53.9 ± 16.4

64.4 ± 17.1

0.003

Max temperature

38.3 ± 1.0

37.7 ± 0.8

0.002

Min temperature

36.0 ± 0.70

36.4 ± 0.7

0.03

Log2 PCT

2.58 ± 3.10

− 0.46 ± 3.82

0.001

Patients with identified sites of infection (N = 97) were stratified into the following subgroups: non-respiratory (abdominal + urinary + other; N = 48) and
respiratory (pneumonia + non-pneumonia; N = 49). Parameters that varied significantly (p < 0.05) between these two groups were identified by statistical testing (t
test for continuous parameters; two-proportions z-test for categorical parameters)
1
Two-tailed t test for all parameters except for overall agreement and number of indeterminates, for which a two-proportion z-test was run
instead (www.vassarstats.net)
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Fig. 3 Logistic regression analysis to distinguish indeterminates from
patients with either sepsis or SIRS. a Logistic regression model for
sepsis vs. indeterminates. The model used consensus discharge
diagnosis by the site investigators as the comparator and analyzed 64
septic patients and 23 indeterminates. The predictor variable is given
by the following equation: y = 0.4249 + 0.3672 * SeptiScore + 0.1232 *
WBC.Max − 0.0245 * WBC.Min − 0.0269 * MAP.Max. This equation gives
AUC = 0.79 (95% CI 0.68–0.90) in ROC curve analysis. b Logistic
regression model for SIRS vs. indeterminates. The model used
consensus discharge diagnosis by the site investigators as the
comparator and analyzed 73 SIRS patients and 15 indeterminates. The
predictor variable is given by the following equation: y = 3.1742–0.2548
* log2 PCT − 0.3913 * SeptiScore. This equation gives AUC = 0.81 (95%
CI 0.69–0.92) in ROC curve analysis. Additional file 6 provides further
details of the analysis. Abbreviations: AUC, area under curve; MAP.Max,
maximum mean arterial blood pressure; PCT, procalcitonin; ROC,
receiver operating characteristic curve; WBC.Max, maximum white
blood cell count; WBC.Min, minimum white blood cell count
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between physicians and nurses [35], between ED physicians and hospitalists [36], or between physicians on a
post hoc basis [19]. In the last-named comparison, using
all available clinical information, inter-observer agreement
varied considerably, with lowest levels of agreement for
ventilator-associated pneumonia. The reported variation
in agreement on a post hoc basis demonstrates the challenges faced by physicians in accurate sepsis diagnosis at
the time of patient presentation, when clinical information
is limited.
Following from this earlier work, we conducted a post
hoc analysis of previously collected data from a prospective, observational trial of 249 adult subjects who
fulfilled ≥ 2 SIRS criteria. The subjects were recruited
from the ICUs of seven hospitals in the USA. We sought
to determine the degree to which existing clinical approaches were able to distinguish sepsis from
non-infectious causes of SIRS. Physicians with different
levels of training and experience (attending physicians,
site investigators, and external expert panelists) were
asked to make diagnostic calls of either SIRS, sepsis, or
indeterminate, based on varying amounts of clinical information available. Agreement between evaluators was
quantified using overall percent agreement and the
free-marginal and fixed-marginal variants of the
inter-observer agreement kappa statistic (κfree and κfixed,
respectively).
Our study extends the previous work on this topic because it quantifies differences in sepsis diagnosis based
on timing and availability of clinical information, physician training, hospital location, and/or infection site. It
also attempts to identify significant clinical variables
underlying the observed heterogeneity within the group
of patients with indeterminate diagnoses. Finally, it employs machine learning methods to attempt to identify
clinical variables that could explain why, of the patients
diagnosed as SIRS, some were prescribed antibiotics and
some were not.
We identified the following key factors affecting the
inter-observer agreement values: (1) the type and
amount of clinical information available (initial impression upon ICU admission vs. discharge impression or
RPD) and (2) whether the infection was respiratory in
origin or arose in some other body site. In general, physician agreement was moderate (κfree ~ 0.7) for diagnosing either SIRS or sepsis due to non-respiratory
infections. The agreement for diagnosing sepsis due to
respiratory infections was significantly lower (κfree ~ 0.3).
This last finding appears to be consistent with other reports from the literature [19, 37–39].
An important aspect of our study is the capture of the
initial admitting impression and its comparison to later
diagnosis at ICU discharge or by expert panel. We believe the admission classification of the attending
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Fig. 4 Analysis of subjects treated with therapeutic antibiotics as a function of diagnosis, evaluation method, and cohort: fraction of subjects treated.
The case report forms indicated whether or not particular patients were treated with therapeutic antibiotics. A diagnosis of SIRS, indeterminate, or
sepsis was made by (1) attending physician at admission, (2) site investigator at admission, (3) site investigators’ consensus at discharge, (4) consensus
RPD, or (5) unanimous RPD

physician best represents real world decision-making
process, and realistically embodies the expected clinical
variability in clinical judgement which is often subjective
in nature early in a disease course. We found that a physician’s initial clinical impression often disagreed with
the final diagnosis, with a tendency to over diagnose sepsis early, as 30% of those reclassified were initially determined to be septic by the treating physicians.
We found low inter-observer agreement for differentiating SIRS vs. sepsis in cases of respiratory infections
(Fig. 3 and Additional file 4), consistent with other reports from the literature [19, 37–39]. Earlier studies have
shown a poor predictive value of the use of clinical signs
and symptoms in detecting radiographic pneumonia
[40]. Similarly, chest x-ray has also been shown to be inaccurate with poor inter-observer agreement in diagnosing pneumonia when compared to quantitative
respiratory cultures collected by protected brush specimens [41]. Clearly, accurate diagnostic tests that improve a physician’s ability to distinguish between
pneumonia, viral causes of respiratory tract infection,
and non-infectious inflammatory processes are needed.
A noteworthy observation from our study is that ~
60% of patients ultimately classified as having SIRS
nonetheless were given systemic antibiotics. An extensive bioinformatics analysis failed to identify variables, or
combinations of variables, that could definitively discriminate between SIRS patients that did or did not receive systemic antibiotics: the best combination of
variables produced a ROC AUC of only ~ 0.7 between
these groups. The early use of antibiotics in patients

with SIRS suggests that physicians, when confronted
with critically ill patients displaying systemic signs and
symptoms that could indicate the presence of sepsis—
and prior to establishing a definitive diagnosis—will take
vigorous measures to initiate antibiotics early, which is a
practice supported by the scientific literature, national
guidelines, and the Surviving Sepsis Campaign [42–44].
The fact that antibiotic use was so frequent in patients
who did not have infection highlights the need for better
strategies to reduce the burden and duration of unnecessary antibiotic use.
Our study has several limitations. First, due to practical constraints, it was not possible for the attending
physician and the site investigator to provide the admission evaluation concurrently. Some component of the
disagreement between the initial assessments of the attending physician and the site investigator may therefore
have been due to differences in the (time-dependent)
availability of information used to make this early assessment, rather than to differences in data interpretation
used to assign infection likelihoods. However, generally
the initial assessments of the attending physician and
site investigator were performed within hours of each
other, and therefore drew from very similar available
data in the electronic medical record. In all cases, both
opinions were rendered before microbiological results
became available. Thus there was little opportunity for
differences in assessment by attending physician and site
investigator to derive from the arrival of definitive (i.e.,
microbiological culture) evidence in the intervening time
period. Second, the external RPD panelists had access to
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Table 5 Test for the ability of clinical parameters to distinguish between SIRS patients who did or did not receive therapeutic
antibiotics
p
value

Parameter

Number of datapoints available1
Patients receiving antibiotics

Patients not receiving antibiotics

MAP.Min

75

52

0.003

HR.Max

78

52

0.007

Temp.Max

78

52

0.011

Hospital LoS

78

52

0.014

N.SIRS

78

52

0.022

SOFA

54

36

0.043

Log2 PCT

51

34

0.054

APACHE

78

51

0.080

WBC.Min

78

51

0.153

pH

34

17

0.183

Age

78

52

0.272

Race: non-white

23/78 (29.5%)

20/52 (38.5%)

0.286

Race: white

55/78 (70.5%)

32/52 (61.5%)

0.286

WBC.Max

78

51

0.352

Glucose.Max

68

46

0.406

SeptiScore

78

52

0.413

Sex: female

35/78 (44.9%)

27/52 (51.9%)

0.430

Sex: male

43/78 (55.1%)

25/52 (48.1%)

0.430

Lactate

39

17

0.473

MAP.Max

58

42

0.694

ICU LoS

78

52

0.749

Temp.Min

74

51

0.760

HR.Min

78

52

0.960

Diagnosis of SIRS (N = 130) was by consensus RPD. Parameters are listed on the basis of decreasing significance (two-tailed p value) as evaluated either by t test
(for continuous variables) or by a two-proportions z-test (www.vassarstats.net) for categorical variables
Abbreviations: Glucose.Max maximum blood glucose concentration, HR.Max maximum heart rate, HR.Min minimum heart rate, ICU LoS length of stay in ICU (days),
MAP.Max maximum mean arterial blood pressure, MAP.Min minimum mean arterial blood pressure, N.SIRS number of SIRS criteria met, Temp.Max maximum core
temperature, Temp.Min minimum core temperature, WBC.Max maximum white blood cell count, WBC.Min minimum white blood cell count
1
No imputation of missing values was performed

the site investigators’ retrospective discharge assessment
for each patient, which means there was no complete independence between these two assessments. Third, by
design, we did not power the underlying study for stratification with the exception of the different cohorts
(VENUS, VENUS supplemental) and pneumonia as an
infection source. There could be other strata-specific
diagnostic discordances that were not readily observable
because of the limited size of our cohorts. In the case of
pneumonia, which was targeted a priori, we observed a
marked and significant decrease in diagnostic agreement
in this stratum compared to other infection sources.
Lung conditions are diverse in etiology, and an additional
study powered to provide insight into this important patient group could be valuable.
We believe the true level of diagnostic uncertainty encountered in clinical practice may be underestimated by

the percent overall agreement and inter-observer agreement statistics used in this study. Factors not addressed
in our analysis that could contribute to additional diagnostic uncertainty include: (1) inherent subjectivity in
result interpretation by physicians, (2) unknown institutional (site) differences including the use of decision
support tools (see Additional file 5), (3) demographic or
clinical heterogeneity, and (4) uncertainty in SIRS and
sepsis definitions. It is interesting that there were 8/249
(3.2%) truly ambiguous cases, for which the discharge
evaluation by the adjudicator matched neither evaluation
by the site investigators. We believe that these eight
truly ambiguous cases most likely represent a background level of “inherent diagnostic noise” that could
not be eliminated from the study. Removal of these patients did not significantly change the study’s conclusions (not shown).
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clinical impressions made on admission to ICUs moderately agreed with the final clinical diagnosis as determined by experienced site investigators and by an
external expert panel of specialists. The highest level of
disagreement was observed in patients with respiratory
tract symptoms. Antibiotic use was widespread and not
always indicated, with over 50% of patients initially
thought to have SIRS receiving empiric treatment on admission. Our findings further underscore the need for
improved diagnostic tests that can be applied early in a
patient’s hospitalization to better guide therapeutic decisions that include the withholding of antibiotics.

Additional files
Additional file 1: Comparison of Different Kappa Statistics. Figure S1–1.
Sample size dependence of the κfree/κfixed ratio. Data were taken from the USA
cohort, stratified by hospital collection site (Additional file 5). Figure S1–2. Different
kappa statistics, plotted as a function of overall percent agreement. Data were
generated from the stratification analysis with respect to hospital collection site
(Additional file 5). (PDF 215 kb)
Additional file 2: Line Data File. (XLS 425 kb)
Additional file 3: Analysis of Reclassification Events. Figure S3–1.
Reclassification events between the initial impression by the attending
physician and the consensus discharge evaluation by site investigators.
Figure S3–2. Reclassification events between the initial impression by
the attending physician and the RPD. (PDF 333 kb)

Fig. 5 Analysis of subjects treated with therapeutic antibiotics as a
function of diagnosis, evaluation method, and cohort: logistic
regression models. a Discrimination of SIRS patients who were treated
vs. not treated with therapeutic antibiotics, using a five-variable logistic
model (y = − 17.8210 − 0.0200 * MAP.Min + 0.0128 * HR.Max + 0.4540 *
Temp.Max + 0.0906 * Hospital.LoS + 0.2472 * N.SIRS). The model gave
AUC 0.72 (95% CI 0.63–0.81) in ROC curve analysis. b Discrimination of
SIRS patients who were treated vs. not treated with therapeutic
antibiotics using a four-variable logistic model (y = − 16.5106 - 0.0239 *
MAP.Min + 0.0125 * HR.Max + 0.4372 * Temp.Max + 0.2386 * N.SIRS).
The model gave AUC 0.71 (95% CI 0.62–0.80) in ROC curve analysis.
Additional file 7 provides further details. Abbreviations: AUC, area
under curve; Hospital.LoS, length of stay in hospital; HR.Max, maximum
heart rate; MAP.Min, minimum mean arterial blood pressure; N.SIRS,
number of SIRS criteria met; ROC, receiver operating characteristic
curve; Temp.Max, maximum core temperature; WBC.Max, maximum
white blood cell count; WBC.Min, minimum white blood cell count

Conclusions
In a post hoc analysis of data from a prospectively enrolled, multicenter cohort, we found that the initial

Additional file 4: Patients with Respiratory Infections. Figure S4–1.
Cumulative distributions of the overall percent agreement statistic for
respiratory infections vs. non-respiratory infections + SIRS, calculated from
Tables S4–1 and S4–2. The Kolmogorov-Smirnov test indicated a highly
significant difference (p < 0.0001). Figure S4–2. Cumulative distributions
of the free marginal kappa statistic (κfree) for respiratory infections vs.
non-respiratory infections + SIRS, calculated from Tables S4–1 and S4–2.
The Kolmogorov-Smirnov test indicated a highly significant difference (p
< 0.0001). Figure S4–3. Measured classification discordance in the VENUS
+ VENUS supplement cohorts (N = 49). (A) Comparison of initial evaluations by attending physician and site investigator (67.3% overall agreement; κfree = 0.51). (B) Comparison of the attending physician’s initial
evaluation and site investigators’ discharge evaluation (49.0% overall
agreement; κfree = 0.24). (C) Comparison of discharge assessments between site investigators (67.3% overall agreement; κfree = 0.51). (D) Comparison of site investigators’ consensus discharge assessment and
external RPD (65.3% overall agreement; κfree = 0.48). Figure S4–4. Measured classification discordance in the VENUS + VENUS supplement cohorts without respiratory infections (N = 207). (A) Comparison of the initial
evaluations of the attending physician and the site investigator (80.5%
overall agreement; κfree = 0.71). (B) Comparison of attending physician’s
initial evaluation and site investigators’ consensus discharge evaluation
(81.0% overall agreement; κfree = 0.72). (C) Comparison of discharge assessments between site investigators (93.0% overall agreement; κfree =
0.90). (D) Comparison of site investigators’ consensus discharge assessment and external RPD (91.0% overall agreement; κfree = 0.86). Figure S4–
5. Cumulative Distributions of the Indeterminate Vote Fraction, for patients suspected of pneumonia or non-pneumonia respiratory infections
(N = 49) versus patients not suspected of these conditions (N = 200).
Table S4–1. Pairwise comparisons: respiratory infections. Table S4–2.
Pairwise comparisons: non-respiratory infections + SIRS (PDF 640 kb)
Additional file 5: Stratification by Hospital. Figure S5–1. Plot of overall
agreement and κfree for different diagnostic methods at different US
hospitals. Values are plotted for (U) the entire USA Cohort (N = 249) and
individually for different sub-cohorts: hospital #1 (N = 129), hospital #2 (N =
11), hospital #3 (N = 39), hospital #4 (N = 26), hospital #5 (N = 37), and (6)
hospital #6 (N = 7). Note that (U) = hospitals #1 + 2 + 3 + 4 + 5 + 6. Orange
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bars: overall percent agreement. Blue bars: free-marginal kappa. The comparisons were as follows: (A) initial assessment by attending physician vs. initial
assessment by site investigator; (B) initial assessment by attending physician
vs. consensus discharge assessment by site investigators; (C) initial assessment by attending physician vs. RPD consensus; (D) initial assessment by
site investigator vs. consensus discharge assessment by site investigators; (E)
initial assessment by site investigator vs. RPD consensus; (F) consensus discharge assessment by site investigators vs. RPD consensus. Table S5–1. Parameters with significant differences (p < 0.05) between hospital subgroups
(hospitals #2, 3) versus (hospitals #5, 6). These two US hospital subgroups
displayed the least vs. greatest agreement between the initial diagnosis at
admission and later discharge or retrospective diagnoses. (PDF 479 kb)
Additional file 6: Analysis of Indeterminates. Figure S6–1. ROC curve
analysis. Panel A: discrimination of sepsis vs. indeterminate, using the variable
MAP.Max. Panel B: discrimination of SIRS vs. indeterminate, using the variable
Temp.Max. Figure S6–2. Logistic regression model for sepsis vs. indeterminates.
The predictor variable is given by the following equation: y = 0.4249 + 0.3672 *
SeptiScore + 0.1232 * WBC.Max − 0.0245 * WBC.Min − 0.0269 * MAP.Max. This
equation gives AUC = 0.79 (95% CI 0.68–0.90) in ROC curve analysis. Figure S6–
3. Logistic regression model for SIRS vs. indeterminates. The predictor variable is
given by the following equation: y = 3.1742–0.2548 * log2 PCT − 0.3913 *
SeptiScore. This equation gives AUC = 0.81 (95% CI 0.69–0.92) in ROC curve
analysis. Table S6–1. Comparison of clinical parameters for patients classified as
sepsis, SIRS, or indeterminate, when consensus discharge by site investigators is
the comparator. Dataset = Venus + Venus supplement (N = 249). Mean ± SD
values are indicated. Significance testing: 2-tailed t test for continuous variables
with equal variances assumed (Excel); two-proportion Z-test for categorical variables (http://www.socscistatistics.com/tests/ztest/Default2.aspx). Variables that
show significant (p < 0.05) differences between sepsis/indeterminate groups, or
between SIRS/indeterminate groups, are highlighted in pink. Table S6–2. Logistic regression to discriminate indeterminates from sepsis. Table S6–3. Logistic regression to discriminate indeterminates from SIRS. Table S6–4. Summary of
logistic regression analysis (PDF 558 kb)
Additional file 7: Analysis of Treated vs. Untreated SIRS Patients. Figure
S7–1. Behavior of logistic regression models in ROC curve analysis. (A) Five
variable model from Table S7–2, giving AUC = 0.72 (95% CI 0.63–0.81). (B)
Four variable model from Table S7–3, giving AUC = 0.71 (95% CI 0.62–0.80).
Figure S7–2. Machine learning attempts to identify combinations of clinical
variables and demographic variables that discriminate between antibiotic
treatment and no treatment, within the SIRS group. Recursive feature
elimination was used, within a logistic regression (LR) or Random Forests
(RF) model. Figure S7–3. Gini ranking of individual words in the “physician
comments” field of the case report form, for SIRS patients. The ranking is
based on contribution toward discriminating antibiotic-treated vs. untreated
SIRS patients. Abbreviations: cxr, chest x-ray; dka, diabetic ketoacidosis; mri,
magnetic resonance imaging. Figure S7–4. Gini ranking of word-pairs in
the “physician comments” field of the case report form, for SIRS patients.
The ranking is based on contribution toward discriminating antibiotictreated vs. untreated SIRS patients. Abbreviation: chf, congestive heart failure. Figure S7–5. Machine learning attempt to identify combinations of
clinical variables, demographic variables, words, and word-pairs that discriminate between antibiotic treatment and no treatment, within the SIRS group.
Recursive feature elimination was used, within a logistic regression (LR) or
Random Forests (RF) model. Table S7–1. Test for ability of clinical and
demographic parameters to distinguish between SIRS patients who received (AB+) or did not receive (AB−) therapeutic antibiotics. Diagnosis was
by consensus RPD. Parameters are listed in order of decreasing significance
(2-tailed p-value) as evaluated either by Student’s t test, assuming equal variances in the two groups (for continuous variables), or by a 2-proportions ztest (www.vassarstats.net) for categorical variables. Table S7–2. Use of logistic regression, to discriminate between SIRS patients who were treated vs.
not treated with antibiotics. Five variable model. Table S7–3. Use of logistic
regression, to discriminate between SIRS patients who were treated vs. not
treated with antibiotics. Four variable model. (PDF 550 kb)
Additional file 8: STROBE Checklist. (XLSX 14 kb)
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